Cyberknife® system: a new therapeutic strategy for sinonasal solitary extramedullary plasmacytomae

E. Cantone, V. Borzillo, A.M.Di Lullo, L. Marano, E. Guadagno, G. Mansueto, R.Di Franco, F. Cammarota, L. Catalano, P. Muto, M. Iengo

Article ID: 4384
Vol 31, Issue 3, 2017
DOI: https://doi.org/10.54517/jbrha4384
Received: 6 June 2022; Accepted: 6 June 2022; Available online: 6 June 2022; Issue release: 6 June 2022

Abstract

Sino-nasal solitary extramedullary plasmacytoma (EMP) is a rare neoplasm with unpredictable progression to multiple myeloma. To improve the precision of irradiation delivery, preserving the healthy surrounding tissue and critical structures we used a CyberKnife® for the treatment of sinonasal solitary extramedullary plasmacytoma. We present the first case of sinonasal-EMP treated with CyberKnife®-stereotactic radiotherapy (SRT) with a complete remission without adverse events. Based on the post-therapeutic results and healthy tissue preservation, we believe that CyberKnife®-SRT represents a good therapeutic option for the treatment of sinonasal-EMP.


Keywords

plasmacytoma;sinunasal;stereotactic radiotherapy;radiosurgery;plasma cell;epistaxis


References

Supporting Agencies



Copyright (c) 2017 E. Cantone, V. Borzillo, A.M.Di Lullo, L. Marano, E. Guadagno, G. Mansueto, R.Di Franco, F. Cammarota, L. Catalano, P. Muto, M. Iengo




This site is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).